US Patent 11414433 Heterocyclic compounds as immunomodulators
Patent 11414433 was granted and assigned to Incyte on August, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11414433 Heterocyclic compounds as immunomodulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.